메뉴 건너뛰기




Volumn 359, Issue 9301, 2002, Pages 92-93

No reduction in cardiovascular risk with NSAIDs - Including aspirin?

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN; ROFECOXIB;

EID: 0037065571     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)07332-4     Document Type: Note
Times cited : (24)

References (12)
  • 11
    • 0034725355 scopus 로고    scopus 로고
    • Prevalence, clinical characteristics and mortality among patients with myocardial infarction presenting without chest pain
    • (2000) JAMA , vol.283 , pp. 3223-3229
    • Canto, J.G.1    Shlipak, M.G.2    Rogers, W.J.3
  • 12
    • 0034655567 scopus 로고    scopus 로고
    • Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial
    • (2000) Lancet , vol.355 , pp. 1295-1302


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.